ATE501759T1 - Metallbeschichtete nanopartikeln zur anwendung in der behandlung der enzymatischen dermatitis - Google Patents
Metallbeschichtete nanopartikeln zur anwendung in der behandlung der enzymatischen dermatitisInfo
- Publication number
- ATE501759T1 ATE501759T1 AT07868587T AT07868587T ATE501759T1 AT E501759 T1 ATE501759 T1 AT E501759T1 AT 07868587 T AT07868587 T AT 07868587T AT 07868587 T AT07868587 T AT 07868587T AT E501759 T1 ATE501759 T1 AT E501759T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- metal coated
- coated nanoparticles
- enzymatic dermatitis
- dermatitis
- Prior art date
Links
- 229910052751 metal Inorganic materials 0.000 title abstract 3
- 239000002184 metal Substances 0.000 title abstract 3
- 239000002105 nanoparticle Substances 0.000 title abstract 3
- 201000004624 Dermatitis Diseases 0.000 title abstract 2
- 230000002255 enzymatic effect Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- 229910052782 aluminium Inorganic materials 0.000 abstract 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 230000018791 negative regulation of catalytic activity Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Optics & Photonics (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/554,214 US20080103459A1 (en) | 2006-10-30 | 2006-10-30 | Enzyme inhibition using nanoparticles |
| PCT/US2007/082603 WO2008055049A2 (en) | 2006-10-30 | 2007-10-26 | Enzyme inhibition using nanoparticles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE501759T1 true ATE501759T1 (de) | 2011-04-15 |
Family
ID=39331215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07868587T ATE501759T1 (de) | 2006-10-30 | 2007-10-26 | Metallbeschichtete nanopartikeln zur anwendung in der behandlung der enzymatischen dermatitis |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080103459A1 (de) |
| EP (1) | EP2083796B1 (de) |
| JP (1) | JP2010508356A (de) |
| CN (1) | CN101557800B (de) |
| AT (1) | ATE501759T1 (de) |
| AU (1) | AU2007313799A1 (de) |
| BR (1) | BRPI0717880A2 (de) |
| CA (1) | CA2667953A1 (de) |
| CO (1) | CO6210804A2 (de) |
| DE (1) | DE602007013266D1 (de) |
| ES (1) | ES2360638T3 (de) |
| MX (1) | MX2009004787A (de) |
| RU (1) | RU2009120470A (de) |
| WO (1) | WO2008055049A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060134052A1 (en) * | 2004-12-17 | 2006-06-22 | Cossa Anthony J | Compositions comprising polymeric emulsifiers and methods of using same |
| RU2460532C1 (ru) * | 2011-04-28 | 2012-09-10 | Учреждение Российской академии наук Институт энергетических проблем химической физики РАН | Препарат, ускоряющий ранозаживление |
| US20140154468A1 (en) * | 2012-12-05 | 2014-06-05 | National Taiwan University | Composite of size-controllable metal nanoparticales and the method of making the same |
| EP2946805A4 (de) * | 2013-01-21 | 2016-10-26 | Bukyoung Pharm Co Ltd | Mikronadel, form zur herstellung davon und herstellungsverfahren dafür |
| JP2014234334A (ja) * | 2013-06-04 | 2014-12-15 | Dic株式会社 | 金属ナノ粒子／層状鉱物複合体及びその製造方法 |
| US20180243336A1 (en) * | 2015-08-28 | 2018-08-30 | The Regents Of The University Of Michigan | Antimicrobial and enzyme inhibitory zinc oxide nanoparticles |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4556560A (en) * | 1983-01-24 | 1985-12-03 | The Procter & Gamble Company | Methods for the treatment and prophylaxis of diaper rash and diaper dermatitis |
| FR2651125B1 (fr) * | 1989-08-23 | 1992-10-02 | Roussel Uclaf | Compositions pharmaceutiques de type "pates a l'eau". |
| US6492453B1 (en) | 1999-09-24 | 2002-12-10 | Alphagary Corporation | Low smoke emission, low corrosivity, low toxicity, low heat release, flame retardant, zero halogen polymeric compositions |
| US6464994B1 (en) * | 2000-01-19 | 2002-10-15 | Mentis Technologies, L.C. | Diaper dermatitis preventative medication and a method for making and using same |
| US6939568B2 (en) * | 2001-04-23 | 2005-09-06 | Nucryst Pharmaceuticals Corp. | Treatment of inflammatory skin conditions |
| US20030185901A1 (en) * | 2000-07-27 | 2003-10-02 | Burrell Robert E. | Methods of treating conditions with a metal-containing material |
| US6518324B1 (en) | 2000-11-28 | 2003-02-11 | Atofina Chemicals, Inc. | Polymer foam containing nanoclay |
| CN1330822C (zh) | 2001-01-30 | 2007-08-08 | 宝洁公司 | 用于改善表面的涂层组合物 |
| KR100467205B1 (ko) * | 2001-07-12 | 2005-01-24 | 주식회사 엘지생활건강 | 항균제를 함유하는 일회용 흡수제품 |
| US20030104019A1 (en) * | 2001-11-01 | 2003-06-05 | Mcculloch Laura | Composition for reducing enzymatic irritation to skin |
| US6743463B2 (en) | 2002-03-28 | 2004-06-01 | Scimed Life Systems, Inc. | Method for spray-coating a medical device having a tubular wall such as a stent |
| WO2006074117A2 (en) * | 2005-01-05 | 2006-07-13 | Robert Holladay | Silver/water, silver gels and silver-based compositions; and methods for making and using the same |
| CN1925879B (zh) * | 2003-10-30 | 2011-07-13 | 麦克内尔-Ppc股份有限公司 | 复合材料、其制备方法、以及含有该复合材料的化妆品和药物组合物 |
| JP2005287985A (ja) * | 2004-04-05 | 2005-10-20 | Gha:Kk | 炎症／臭い抑制部材及びその製造方法並びにこれを用いた義体及びギブス |
-
2006
- 2006-10-30 US US11/554,214 patent/US20080103459A1/en not_active Abandoned
-
2007
- 2007-10-26 ES ES07868587T patent/ES2360638T3/es active Active
- 2007-10-26 RU RU2009120470/15A patent/RU2009120470A/ru not_active Application Discontinuation
- 2007-10-26 WO PCT/US2007/082603 patent/WO2008055049A2/en not_active Ceased
- 2007-10-26 MX MX2009004787A patent/MX2009004787A/es active IP Right Grant
- 2007-10-26 AT AT07868587T patent/ATE501759T1/de not_active IP Right Cessation
- 2007-10-26 JP JP2009535403A patent/JP2010508356A/ja active Pending
- 2007-10-26 EP EP07868587A patent/EP2083796B1/de not_active Not-in-force
- 2007-10-26 BR BRPI0717880-8A patent/BRPI0717880A2/pt not_active IP Right Cessation
- 2007-10-26 DE DE602007013266T patent/DE602007013266D1/de active Active
- 2007-10-26 AU AU2007313799A patent/AU2007313799A1/en not_active Abandoned
- 2007-10-26 CN CN2007800465613A patent/CN101557800B/zh not_active Expired - Fee Related
- 2007-10-26 CA CA002667953A patent/CA2667953A1/en not_active Abandoned
-
2009
- 2009-05-11 CO CO09047337A patent/CO6210804A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007313799A1 (en) | 2008-05-08 |
| EP2083796B1 (de) | 2011-03-16 |
| RU2009120470A (ru) | 2010-12-10 |
| WO2008055049A3 (en) | 2008-10-02 |
| DE602007013266D1 (de) | 2011-04-28 |
| US20080103459A1 (en) | 2008-05-01 |
| MX2009004787A (es) | 2009-08-12 |
| ES2360638T3 (es) | 2011-06-07 |
| BRPI0717880A2 (pt) | 2015-06-16 |
| JP2010508356A (ja) | 2010-03-18 |
| WO2008055049A2 (en) | 2008-05-08 |
| CN101557800B (zh) | 2013-04-24 |
| EP2083796A2 (de) | 2009-08-05 |
| CN101557800A (zh) | 2009-10-14 |
| CA2667953A1 (en) | 2008-05-08 |
| CO6210804A2 (es) | 2010-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602007013266D1 (de) | Metallbeschichtete nanopartikeln zur anwendung in der behandlung der enzymatischen dermatitis | |
| WO2007097940A3 (en) | Reca inhibitors with antibiotic activity, compositions and methods of use | |
| PH12011000153A1 (en) | Waxy coatings on plant parts | |
| UA100526C2 (ru) | Способ и композиция для обработки семян | |
| CL2011001557A1 (es) | Articulo abrasivo macroporoso que comprende sustrato de estructura macroporosa y recubrimiento que incluye aglutinante y agregados abrasivos formados desde una composicion de particulas de arenilla abrasivas y aglutinante de nanoparticulas, donde el recubrimiento esta parcialmente incrustado en el sustrato; y metodos. | |
| WO2010056378A3 (en) | Extracellular matrix compositions for the treatment of cancer | |
| EP2313082A4 (de) | Kosmetische zusammensetzung gegen alterung der haut mit extrakten aus dem samen von phaseolus radiatus durch fermentation und enzymbehandlung | |
| WO2009114725A3 (en) | Mobilization op hematopoietic stem cells using cdc42 inhibitors | |
| WO2007001851A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| MY192633A (en) | 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase | |
| WO2007136936A3 (en) | Dermis-derived cells for tissue engineering applications | |
| ATE419859T1 (de) | Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut | |
| WO2009158248A3 (en) | Method and compositions for improving skin and body appearance | |
| WO2009070244A3 (en) | Methods for inhibiting fascin | |
| FI20095616A7 (fi) | Menetelmä huokoisen tuotteen prosessoimiseksi ja huokoinen tuote | |
| MX2015011544A (es) | Metodos y detergentes enzimaticos para la eliminacion de biopelicula. | |
| DE602007008405D1 (de) | Ultrahydrophobische oberflächen und herstellungsverfahren dafür | |
| WO2008092099A8 (en) | Compositions and methods for treating hematopoietic malignancies | |
| WO2011132874A3 (en) | A method for nitriding surface of aluminum or aluminum alloy by cold spray method | |
| DE502005001677D1 (de) | Verfahren zur Herstellung von Beschichtungen mit strukturierter Oberfläche, verwendet insbesondere für Stifte, und Gegenstand mit strukturierter Oberfläche | |
| GB0817578D0 (en) | Method for treating wheel rims and composition for use therein | |
| ATE546297T1 (de) | Herstellung von druckzylindern | |
| MX2009004142A (es) | Metodo para prevenir o tratar sindrome metabolico. | |
| WO2010065861A3 (en) | Inhibitors of bace 1 and methods for treating alzheimer's disease | |
| WO2006104751A3 (en) | Methods and compositions for modulating rho-mediated gene transcription |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |